MDXG
NASDAQ · Biotechnology
Mimedx Group Inc
$4.77
+0.08 (+1.71%)
Analyst Consensus
Strong Buy
11
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+406.3% upside
Low Target
$19.42
Average Target
$24.15
High Target
$35.38
Current Price
$4.77
Current
$4.77
$4.77
Target
$24.15
$24.15
$19.42
$24.15 avg
$35.38
Scenario Analysis
Bear Case
$19.42
307.1%
Low target
Base Case
$24.15
+406.3%
Avg target
Bull Case
$35.38
+641.7%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$7.97
-40.2% from high
52-Week Low
$3.03
+57.4% from low
Target vs 52W High
$24.15
+203.0% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -2.6% |
| AMGN | Hold | 43 | 47% | $190.87 | -51.5% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +140.9% |
| VRTX | Strong Buy | 36 | 81% | $438.34 | -14.2% |
| REGN | Buy | 38 | 68% | $76.80 | -90.4% |
| MRNA | Hold | 30 | 37% | $149.45 | -13.6% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -61.4% |
| RVMD | Strong Buy | 28 | 93% | $114.11 | -40.8% |